Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Mar-24 5:58 PM View:  | Hologic Inc. (HOLX) | 07-Mar-24 | Grant | 1,572 | -- | -- | 4% 43.9K to 45.47K | |
| 16-Feb-24 12:49 PM View: | Incyte Corp (INCY) | 14-Feb-24 | Grant | 7,377 | -- | -- | 9% 82.61K to 89.98K | |
| 14-Feb-24 12:33 PM View: | Incyte Corp (INCY) | 12-Feb-24 | Payment of Exercise | 387 | $57.84 | $22,384.10 | (< 1%) 82.99K to 82.61K | |
| 18-Jul-23 4:00 PM View: | Incyte Corp (INCY) | 14-Jul-23 | Grant | 12,246 | -- | -- | 17% 70.75K to 82.99K | |
| 06-Jul-23 4:00 PM View: | Incyte Corp (INCY) | 03-Jul-23 | Payment of Exercise | 6,073 | $62.08 | $377,012.00 | (8%) 76.82K to 70.75K | |
| 13-Mar-23 4:19 PM View: | Hologic Inc. (HOLX) | 09-Mar-23 | Grant | 1,465 | -- | -- | 3% 42.44K to 43.9K | |
| 15-Feb-23 4:00 PM View: | Incyte Corp (INCY) | 13-Feb-23 | Payment of Exercise | 1,179 | $80.08 | $94,414.30 | (2%) 77.64K to 76.46K | |
| 24-Jan-23 4:00 PM View: | Incyte Corp (INCY) | 20-Jan-23 | Grant | 4,980 | -- | -- | 7% 72.66K to 77.64K | |
| 06-Jul-22 4:10 PM View: | Incyte Corp (INCY) | 05-Jul-22 | Payment of Exercise | 1,124 | $79.25 | $89,077.00 | (2%) 73.78K to 72.66K | |
| 06-Jul-22 4:10 PM View: | Incyte Corp (INCY) | 02-Jul-22 | Grant | 17,317 | -- | -- | 31% 56.47K to 73.78K | |
| 14-Mar-22 4:33 PM View: | Hologic Inc. (HOLX) | 10-Mar-22 | Grant | 1,565 | -- | -- | 4% 40.87K to 42.44K | |
| 15-Feb-22 4:21 PM View: | Incyte Corp (INCY) | 11-Feb-22 | Payment of Exercise | 1,177 | $66.76 | $78,576.50 | (2%) 57.46K to 56.28K | (12%) |
| 05-Jan-22 4:19 PM View: | Incyte Corp (INCY) | 01-Jan-22 | Grant | 14,463 | -- | -- | 34% 43.0K to 57.46K | |
| 23-Nov-21 4:22 PM View: | Incyte Corp (INCY) | 19-Nov-21 | Grant | 2,734 | -- | -- | 7% 40.27K to 43.0K | |
| 07-Jul-21 4:39 PM View: | Incyte Corp (INCY) | 02-Jul-21 | Grant | 7,853 | -- | -- | 24% 32.93K to 40.78K | |
| 07-Jul-21 4:39 PM View: | Incyte Corp (INCY) | 02-Jul-21 | Payment of Exercise | 516 | -- | -- | (1%) 40.78K to 40.27K | |
| 15-Mar-21 6:20 PM View: | Hologic Inc. (HOLX) | 11-Mar-21 | Grant | 1,478 | -- | -- | 4% 39.39K to 40.87K | |
| 16-Feb-21 4:40 PM View: | Incyte Corp (INCY) | 11-Feb-21 | Payment of Exercise | 1,210 | $84.99 | $102,838.00 | (4%) 33.82K to 32.61K | < 1% |
| 20-Jan-21 6:02 PM View: | Incyte Corp (INCY) | 15-Jan-21 | Grant | 11,522 | -- | -- | 52% 22.3K to 33.82K | |
| 18-Nov-20 4:46 PM View: | Incyte Corp (INCY) | 16-Nov-20 | Grant | 1,232 | -- | -- | 6% 21.07K to 22.3K | |
| 06-Nov-20 4:10 PM View: | Hologic Inc. (HOLX) | 04-Nov-20 | Option Exercise | 11,146 | $22.35 | $249,113.00 | 28% 39.39K to 50.54K | |
| 06-Nov-20 4:10 PM View: | Hologic Inc. (HOLX) | 04-Nov-20 | Market Option Sale (Planned) | 11,146 | $74.00 | $824,804.00 | (22%) 50.54K to 39.39K | (1%) |
| 07-Jul-20 7:24 PM View: | Incyte Corp (INCY) | 02-Jul-20 | Grant | 6,661 | -- | -- | 46% 14.41K to 21.07K | |
| 09-Mar-20 5:08 PM View: | Hologic Inc. (HOLX) | 05-Mar-20 | Grant | 2,217 | -- | -- | 6% 37.17K to 39.39K | |
| 13-Feb-20 5:21 PM View: | Incyte Corp (INCY) | 11-Feb-20 | Grant | 4,268 | $76.14 | $324,966.00 | 40% 10.6K to 14.87K | 15% |
| 13-Feb-20 5:21 PM View: | Incyte Corp (INCY) | 11-Feb-20 | Payment of Exercise | 780 | $76.14 | $59,389.20 | (5%) 14.87K to 14.09K | (15%) |
| 26-Nov-19 4:10 PM View: | Hologic Inc. (HOLX) | 22-Nov-19 | Option Exercise | 12,306 | $20.01 | $246,243.00 | 33% 37.17K to 49.48K | |
| 26-Nov-19 4:10 PM View: | Hologic Inc. (HOLX) | 22-Nov-19 | Market Option Sale | 12,306 | $49.75 | $612,224.00 | (25%) 49.48K to 37.17K | (51%) |
| 11-Mar-19 4:34 PM View: | Hologic Inc. (HOLX) | 07-Mar-19 | Grant | 2,136 | -- | -- | 6% 35.04K to 37.17K | |
| 13-Feb-19 4:20 PM View: | Incyte Corp (INCY) | 11-Feb-19 | Grant | 10,285 | $80.21 | $824,960.00 | 100% 0 to 10.29K | 9% |
| 30-Nov-18 4:19 PM View: | Hologic Inc. (HOLX) | 28-Nov-18 | Option Exercise | 13,257 | $17.51 | $232,130.00 | 38% 35.04K to 48.3K | |
| 30-Nov-18 4:19 PM View: | Hologic Inc. (HOLX) | 28-Nov-18 | Market Option Sale (Planned) | 13,257 | $44.50 | $589,950.00 | (27%) 48.3K to 35.04K | (69%) |
| 04-Oct-18 4:39 PM View: | Hologic Inc. (HOLX) | 02-Oct-18 | Option Exercise | 30,967 | $15.29 | $473,485.00 | 88% 35.04K to 66.01K | |
| 04-Oct-18 4:39 PM View: | Hologic Inc. (HOLX) | 02-Oct-18 | Market Option Sale (Planned) | 30,967 | $40.70 | $1,260,480.00 | (47%) 66.01K to 35.04K | (84%) |
| 16-Mar-18 4:30 PM View: | Hologic Inc. (HOLX) | 14-Mar-18 | Grant | 2,406 | -- | -- | 7% 32.63K to 35.04K | |
| 09-Mar-17 4:38 PM View: | Hologic Inc. (HOLX) | 08-Mar-17 | Grant | 2,206 | -- | -- | 8% 28.0K to 30.21K | |
| 09-Mar-17 4:38 PM View: | Hologic Inc. (HOLX) | 08-Mar-17 | Option Exercise | 2,427 | -- | -- | 8% 30.21K to 32.63K | |
| 05-Jan-16 5:53 PM View: | Hologic Inc. (HOLX) | 01-Jan-16 | Option Exercise | 3,272 | -- | -- | 13% 24.73K to 28.0K | |
| 05-Jan-15 4:13 PM View: | Hologic Inc. (HOLX) | 01-Jan-15 | Option Exercise | 3,914 | $26.74 | $104,660.00 | 19% 20.81K to 24.73K | 181% |
| 17-Jul-13 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Jul-13 | Option Exercise | 1,125 | $33.82 | $38,047.50 | 3% 41.65K to 42.78K | |
| 17-Jul-13 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Jul-13 | Market Option Sale (Planned) | 1,125 | $86.35 | $97,139.20 | (3%) 42.78K to 41.65K | (102%) |
| 09-Jul-13 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Jul-13 | Option Exercise | 4,687 | $34.57 | $162,030.00 | 11% 41.65K to 46.34K | |
| 09-Jul-13 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Jul-13 | Market Option Sale (Planned) | 4,687 | $81.21 | $380,615.00 | (10%) 46.34K to 41.65K | (115%) |
| 17-May-13 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-May-13 | Market Sale (Planned) | 602 | $79.65 | $47,949.00 | (1%) 42.25K to 41.65K | (119%) |
| 01-May-13 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Apr-13 | Option Exercise | 1 | $34.57 | $34.57 | < 1% 139.92K to 139.92K | |
| 01-May-13 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Apr-13 | Market Sale (Planned) | 1 | $77.88 | $77.88 | (< 1%) 139.92K to 139.92K | (124%) |
| 01-May-13 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-13 | Option Exercise | 77,999 | $34.45 | $2,687,140.00 | 54% 144.92K to 222.92K | |
| 01-May-13 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-13 | Market Option Sale (Planned) | 78,000 | $79.50 | $6,201,320.00 | (35%) 222.92K to 144.92K | (120%) |
| 01-May-13 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-13 | Market Sale (Planned) | 4,999 | $79.50 | $397,441.00 | (3%) 144.92K to 139.92K | (120%) |
| 07-Feb-13 5:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-13 | Grant | 10,166 | $0.01 | $101.66 | 28% 36.34K to 46.51K |